Radient Pharmaceuticals Corporation fka RXPC

[Gold Seeker]

dcspka, Radient has no method at all of resolving their $22 million of debt. They cannot issue any more shares. That's all over because they cannot do another reverse split without shareholder authorization which costs MONEY.

CIT is old and even if someone attempted to proceed, it would not even be at the point of possible FDA action before the patent expired. That is why it was totally written off.

Onko Sure is proven to have very little value. It wasn't even used for colorectal monitoring as cleared by the FDA because the FDA required it to be used in addition to CEA. No one is going to go to the extra expense of that when the value is not there. Absolutely no one is going to buy Radient or merge with them.